Gao, M.; Liu, F.; Feng, X.; Wang, M.; Zhang, Z.; Li, H.; Wang, C.; Sun, J.
Schisandrin B Alleviates Lipid Metabolism Disorders and Apoptosis of MAFLD via Modulation of PPARγ-PCK1 and Caspase-3 Signaling Pathways. Pharmaceuticals 2025, 18, 1441.
https://doi.org/10.3390/ph18101441
AMA Style
Gao M, Liu F, Feng X, Wang M, Zhang Z, Li H, Wang C, Sun J.
Schisandrin B Alleviates Lipid Metabolism Disorders and Apoptosis of MAFLD via Modulation of PPARγ-PCK1 and Caspase-3 Signaling Pathways. Pharmaceuticals. 2025; 18(10):1441.
https://doi.org/10.3390/ph18101441
Chicago/Turabian Style
Gao, Meng, Feilong Liu, Xiyuan Feng, Mengyang Wang, Zhihong Zhang, He Li, Chunmei Wang, and Jinghui Sun.
2025. "Schisandrin B Alleviates Lipid Metabolism Disorders and Apoptosis of MAFLD via Modulation of PPARγ-PCK1 and Caspase-3 Signaling Pathways" Pharmaceuticals 18, no. 10: 1441.
https://doi.org/10.3390/ph18101441
APA Style
Gao, M., Liu, F., Feng, X., Wang, M., Zhang, Z., Li, H., Wang, C., & Sun, J.
(2025). Schisandrin B Alleviates Lipid Metabolism Disorders and Apoptosis of MAFLD via Modulation of PPARγ-PCK1 and Caspase-3 Signaling Pathways. Pharmaceuticals, 18(10), 1441.
https://doi.org/10.3390/ph18101441